PriceTargets.com logo

NYSE:OSCR - Oscar Health Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $37.83
  • Forecasted Upside: 54.80 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$24.44 As of 04/16/2021 01:00 AM ET
▼ -0.75 (-2.98%)
1 month | 3 months | 12 months
Get New Oscar Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OSCR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OSCR

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$37.83
▲ +54.80% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Oscar Health in the last 3 months. The average price target is $37.83, with a high forecast of $44.00 and a low forecast of $29.00. The average price target represents a 54.80% upside from the last price of $24.44.
Buy
The current consensus among 6 polled investment analysts is to buy stock in Oscar Health.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/25/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/22/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/21/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/19/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/17/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/18/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
4/17/2021

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/29/2021Wells Fargo & CompanyInitiated CoverageOverweight$37.00Low
i
3/29/2021Bank of AmericaInitiated CoverageBuy$39.00Medium
i
3/29/2021Morgan StanleyInitiated CoverageOverweight$44.00Low
i
3/29/2021CowenInitiated CoverageMarket Perform$29.00High
i
3/29/2021The Goldman Sachs GroupInitiated CoverageBuy$44.00High
i
3/29/2021Credit Suisse GroupInitiated CoverageOutperform$34.00High
i
(Data available from 4/17/2016 forward)
Oscar Health logo
Oscar Health, Inc. provides health insurance products and services to individuals, families, and businesses in the United States. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was founded in 2012 and is headquartered in New York, New York.
Read More

Today's Range

Now: $24.44
$24.15
$25.38

50 Day Range

MA: N/A

52 Week Range

Now: $24.44
$22.55
$37.00

Volume

508,571 shs

Average Volume

1,894,330 shs

Market Capitalization

$4.96 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Oscar Health?

The following Wall Street analysts have issued research reports on Oscar Health in the last year: Bank of America Co., Cowen Inc, Credit Suisse Group AG, Morgan Stanley, The Goldman Sachs Group, Inc., and Wells Fargo & Company.
View the latest analyst ratings for OSCR.

What is the current price target for Oscar Health?

6 Wall Street analysts have set twelve-month price targets for Oscar Health in the last year. Their average twelve-month price target is $37.83, suggesting a possible upside of 54.8%. The Goldman Sachs Group, Inc. has the highest price target set, predicting OSCR will reach $44.00 in the next twelve months. Cowen Inc has the lowest price target set, forecasting a price of $29.00 for Oscar Health in the next year.
View the latest price targets for OSCR.

What is the current consensus analyst rating for Oscar Health?

Oscar Health currently has 1 hold rating and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe OSCR will outperform the market and that investors should add to their positions of Oscar Health.
View the latest ratings for OSCR.

What other companies compete with Oscar Health?

Other companies that are similar to Oscar Health include Eisai, Hologic, NovoCure, The Cooper Companies, Insulet, MERCK Kommanditgesellschaft auf Aktien, Eurofins Scientific, UCB, Sino Biopharmaceutical, Catalent, Bio-Rad Laboratories, Sonova, Fresenius Medical Care AG & Co. KGaA, Avantor and Incyte.

How do I contact Oscar Health's investor relations team?

The company's listed phone number is (844) 392-7589. The official website for Oscar Health is www.hioscar.com.